Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide
- 1 January 2000
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 57 (1), 258-264
- https://doi.org/10.1046/j.1523-1755.2000.00832.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Lupus nephritisKidney International, 1997
- Treatment of lupus nephritis: A meta-analysis of clinical trialsAmerican Journal of Kidney Diseases, 1997
- “Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritisKidney International, 1996
- Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic dataKidney International, 1994
- Remission of Lupus Nephritis with Cyclophosphamide and Late Relapses Following Therapy WithdrawalScandinavian Journal of Rheumatology, 1994
- Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide TherapyAnnals of Internal Medicine, 1993
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone onlyArthritis & Rheumatism, 1991
- Therapy of Lupus NephritisThe New England Journal of Medicine, 1986
- Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcomeKidney International, 1984